Prevalence of hepatitis C virus in plasma pools and the effectiveness of cold ethanol fractionation (Q42980364)

12 November 2017

Prevalence of hepatitis C virus in plasma pools and the effectiveness of cold ethanol fractionation (English)

1 reference

12 November 2017

1 reference

Scheiblauer H

1

1 reference

12 November 2017

Nübling M

series ordinal

2

1 reference

12 November 2017

Willkommen H

series ordinal

3

1 reference

12 November 2017

Löwer J

series ordinal

4

1 reference

12 November 2017

1 January 1996

1 reference

12 November 2017

Clinical Therapeutics

1 reference

12 November 2017

18 Suppl B

1 reference

12 November 2017

59-70

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

The Declining Risk of Post-Transfusion Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second‐generation anti‐hepatitis C virus assay

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Screening for hepatitis C virus antibody in plasma for fractionation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Non-A, non-B hepatitis from intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Non-A, non-B hepatitis after intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Non-A, non-B hepatitis transmission by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Hepatitis C virus transmission by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Anti-HCV screening and plasma fractionation: the case against

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Hepatitis C virus antibody prevalence among human immunodeficiency virus-1-infected individuals: analysis with different test systems

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta1-lipoprotein into subfractions of human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Hepatitis C transmission associated with intravenous immunoglobulins.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Safety of intravenous immunoglobulin with regard to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Gammagard and reported hepatitis C virus episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

International collaborative study on the second EUROHEP HCV-RNA reference panel

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Virology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Association of hepatitis C virus in human sera with beta-lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Validation of virus inactivation and removal for the manufacturing procedure of two immunoglobulins and a 5% serum protein solution treated with beta-propiolactone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980196-2

1 reference

7 January 2021

10.1016/S0149-2918(96)80196-2

Identifiers

DOI

1 reference

12 November 2017

1 reference